22nd Joint Meeting of the British Endocrine Societies

Programme: Monday 24 March

Mon 24 Mar | Tues 25 Mar | Wed 26 Mar | Attended Posters


 

The Experts' View
12.00 – 12.45 Dochart Room Chair: Gregory J (Cardiff)
Intersex
Hughes I (Cambridge)
 
The Experts' View
12.00 – 12.45 Carron Room Chair: White M (Liverpool)
Calcium imaging in endocrine cells
Rizzuto R (Ferrara, Italy)
 
The Experts' View
12.00 – 12.45 Forth Room Chair: Vanderpump M (London)
Thyroid eye disease
Wiersinga W (Amsterdam, The Netherlands)
 
LUNCH
12:45 - 13.30 Hall 2
 
Symposium 1: Androgens and prostate cancer
GENEROUSLY SUPPORTED BY ASTRAZENECA PLC
13.30 – 15.00 Dochart Room Chair: McEwan I (Aberdeen)
 
S6 13.30 Androgen action in the prostate
White HC, Gamble SC, Odontiadis M & Bevan CL (London)
S7 14.00 Androgens vs estrogens in prostate cancer
Risbridger GP (Melbourne)
S8 14.30 Survey of gene expression during prostate cancer progression using tissue microarrays
Bubendorf L (Basel)
 
Symposium 2: Trophic control of size
13.30 - 15.00 Carron Room Chair: Henderson I (Sheffield)
 
S9 13.30 Genes and growth and endocrine diseases
Frayling T (Exeter)
S10 14.00 Growth regulation during Drosophila development
Coelho C, Kolevski B & Leevers SJ (London)
S11 14.30 The role of the EG-VEGF family in the regulation of angiogenesis in endocrine glands
Ferrara N (San Francisco), Lecouter J, Lin R & Peale F
 
Clinical Management Workshop: Fatigue-Is it endocrinology?
13.30 - 15.00 Clyde Auditorium Chair: Grossman A (London)
 
S34 13.30 Management of chronic fatigue
Llewelyn MB (Newport)
S35 14.00 The neuroendocrinology of chronic fatigue syndrome
Cleare A (London)
S36 14.30 Psychiatry and chronic fatigue
Sharpe M (Edinburgh)
 
Nurses Interactive Workshop
13.30 - 15.00 Forth Room
Interactive nurses session on patient group directives
Frewin S (Newcastle upon Tyne)
Nurses Tea
GENEROUSLY SPONSORED BY SERONO LTD
15.00 - 15.30 Forth Room
 
TEA/COFFEE
15.00 - 15.30 Hall 2
 
Oral Communications 1: Reproduction and development
15.30 - 17.30 Dochart Room Chair: Hillier S (Edinburgh) &
Risbridger G (Melbourne)
 
OC1 15.30 Agonists of peroxisome proliferator-activated receptor-gamma (PPARg) regulate steroidogenesis in a human granulosa cell line (HGC-5)
Berdiaki A, Jonard S, Chatterjee VKK, Rainey WE & Franks S
OC2 15.45 A functional polymorphism in the extrapituitary prolactin promoter has opposing effects on prolactin gene expression in T-lymphocytes and endometrial stromal cells but is not associated with unexplained recurrent miscarriages
Stevens A, Brintnell W, Worthington J, Zoumpoulidou G, Jivraj S, Regan L, Brosens J & Davis JRE
OC3 16.00 Lipocortin-1 is modulated by glucocorticoids in the human endometrium
Taylor AD, Bedford KJ, Robinson J, Richmond I, Maguiness S, Adams IP & Atkin SL
OC4 16.15 Early developmental indices of placental growth restriction in the overfed adolescent sheep
Lea RG, Hannah LT, Redmer D, Fowler PA, Murray J, Aitken R, Milne JS & Wallace JM
OC5 16.30 Angiotensinogen: The key to programming female hypertension?
O'Regan D, Kenyon CJ, Seckl JR & Holmes MC
OC6 16.45 Hypoxia-ischaemia and the insulin-like growth factor (IGF) family at birth
Pringle PJ, Geary MG, Rodeck CH, Kingdom JCP & Hindmarsh PC
OC7 17.00 Metformin is more effective than Dianette in the treatment of hirsutism in women with PCOS
Harborne L, Norman J, Lyall H & Fleming R
OC8 17.15 Classification of the spectrum of aortic dysmorphology by magnetic resonance imaging in adults with Turner syndrome
Ostberg JE, Brookes J, McCarthy C & Conway GS
 
Oral Communications 2: Cardiovascular endocrinology
15.30 - 17.30 Carron Room Chair: Connell JMC (Glasgow) & Herrington D (Winston-Salem)
 
OC9 15.30 Use of glucocorticoids and risk of cardiovascular disease in a population-based cohort study of 164,133 participants
Wei L, MacDonald TM & Walker BR
OC10 15.45 Genomic analysis of congenic rat strains identifies a new candidate gene for human hypertension
McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ & Dominiczak AF
OC11 16.00 Characterisation of the metabolic syndrome in the stroke prone spontaneously hypertensive rat and the contribution of the Y chromosome
Strahorn P, Graham D, Champange B, Charchar FJ, Crawford L, Sattar N & Dominiczak AF
OC12 16.15 Corticosteroid effects at the trafficking level on the pathway of key importance in blood pressure control
Hou J, Seckl JR, Chapman KE & Brown RW
OC13 16.30 Assessment of the vasodilatory action of testosterone in isolated human pulmonary and mesenteric arteries and veins
Rowell KO, Jones RD, Pugh PJ, Channer KS & Jones TH
OC14 16.45 A single nucleotide polymorphism in the p22phox gene affects arterial compliance
Drummond RS, Brosnan MJ, Lee WK, Kirk A, Pathi V, Hamilton CA & Dominiczak AF
OC15 17.00 A novel PPAR gamma mutation (R357X), associated with partial lipodystrophy, helps define the phenotype of the human PPAR gamma ligand resistance (PLR) syndrome
Agostini M, Rajanayagam O, Smith AG, Savage DB, Labib M, Zalin AM, O'Rahilly S, Trembath RC, Chatterjee VKK & Gurnell M
OC16 17.15 Identification of novel glucocorticoid receptor isoforms in rat and human lung
Pan XJ, Stevens A, Davis JRE & Ray DW
 
Endocrine Nurses Symposium: Ethical dilemmas
15.30 - 17.30 Forth Room Chair: Miller M (Newcastle) & Yeoh P (London)
 
S46 15.30 Understanding the matter of consent
Lilleyman JS (London)
S47 16.10 Ethical implications of tissue retrieval
Campbell K (Glasgow)
S48 16.50 When the results don't match the symptoms: The use and abuse of thyroxine medication in hypothyroidism
Smith J (Sunderland)
 
Clinical Endocrinology Trust Visiting Professor Lecture
17.45 - 18.30 Clyde Auditorium Chair: Rees L (London)
 
S1 17.45 Neuroendocrine regulation of bone mass: GH deficiency and resistance states
Klibanski A (Boston)
 
Welcome Reception
18.30 Hall 2
 
Supper and Ceilidh (entrance by ticket only)
20.00 The Arches